Latest News about SNY
Recent news which mentions SNY
From Benzinga
Viatris Just Snagged a Major FDA Approval
March 03, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Canada Approves First Plant-Based COVID-19 Vaccine
February 25, 2022
From Benzinga
BioMarin Clocks Flat Q4 Sales Despite Erosion oF US Kuvan Market
February 24, 2022
From Benzinga
Why Moderna Stock Is Falling Today
February 23, 2022
From Motley Fool
From Benzinga
2 Green Flags for Novavax's Future
February 23, 2022
From Motley Fool
WHO says omicron subvariant is not stopping global cases from falling, and U.S. nearing 940,000 COVID deaths
February 23, 2022
From MarketWatch
From MarketWatch
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
GSK Halts Late-Stage RSV Vaccine Trial In Pregnant Women
February 18, 2022
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
From Benzinga
From Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
From InvestorPlace
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
From Motley Fool
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
Could This New Indication Create a Blockbuster for Pfizer?
February 05, 2022
From Motley Fool
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
From Benzinga
From Benzinga
Earnings Scheduled For February 4, 2022
February 04, 2022
From Benzinga